Michael Reader

513 total citations
6 papers, 197 citations indexed

About

Michael Reader is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Michael Reader has authored 6 papers receiving a total of 197 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 3 papers in Molecular Biology and 1 paper in Pharmacology. Recurrent topics in Michael Reader's work include Cell death mechanisms and regulation (2 papers), ATP Synthase and ATPases Research (2 papers) and Cyclopropane Reaction Mechanisms (2 papers). Michael Reader is often cited by papers focused on Cell death mechanisms and regulation (2 papers), ATP Synthase and ATPases Research (2 papers) and Cyclopropane Reaction Mechanisms (2 papers). Michael Reader collaborates with scholars based in United Kingdom. Michael Reader's co-authors include Pamela A. Williams, George A. Ward, Christopher N. Johnson, Aman Iqbal, Emiliano Tamanini, Edward J. Lewis, Ildiko M. Buck, Gianni Chessari, James E. H. Day and Sharna J. Rich and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Synlett.

In The Last Decade

Michael Reader

6 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Reader United Kingdom	6	121	84	28	19	18	6	197
James E. H. Day United Kingdom	7	167 1.4×	88 1.0×	42 1.5×	32 1.7×	27 1.5×	9	251
Aman Iqbal United Kingdom	8	199 1.6×	40 0.5×	28 1.0×	41 2.2×	25 1.4×	9	242
David T. Winn United States	9	166 1.4×	106 1.3×	11 0.4×	14 0.7×	41 2.3×	11	282
Rachel M. Vaden United States	8	99 0.8×	109 1.3×	12 0.4×	18 0.9×	27 1.5×	9	236
Fumiyuki Shirai Japan	11	202 1.7×	132 1.6×	18 0.6×	43 2.3×	49 2.7×	27	344
Martin Sendzik Germany	8	87 0.7×	88 1.0×	17 0.6×	23 1.2×	27 1.5×	11	185
Bruce J. Fahr United States	10	146 1.2×	114 1.4×	47 1.7×	14 0.7×	60 3.3×	12	267
Sami Osman United States	8	209 1.7×	86 1.0×	12 0.4×	37 1.9×	33 1.8×	13	290
David R. Cheshire United Kingdom	11	102 0.8×	213 2.5×	32 1.1×	21 1.1×	12 0.7×	13	349
Paul Eastwood Spain	13	105 0.9×	261 3.1×	19 0.7×	15 0.8×	20 1.1×	25	353

Countries citing papers authored by Michael Reader

Since Specialization

Citations

This map shows the geographic impact of Michael Reader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Reader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Reader more than expected).

Fields of papers citing papers by Michael Reader

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Reader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Reader. The network helps show where Michael Reader may publish in the future.

Co-authorship network of co-authors of Michael Reader

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Reader. A scholar is included among the top collaborators of Michael Reader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Reader. Michael Reader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Tamanini, Emiliano, Ildiko M. Buck, Gianni Chessari, et al.. (2017). Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP). Journal of Medicinal Chemistry. 60(11). 4611–4625. 57 indexed citations

2.

Chessari, Gianni, Ildiko M. Buck, James E. H. Day, et al.. (2015). Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP. Journal of Medicinal Chemistry. 58(16). 6574–6588. 67 indexed citations

3.

Day, James E. H., et al.. (2015). The Synthesis of 3,3-Dimethyl Aza- and Diazaindolines Using a Palladium-Catalysed Intramolecular Reductive Cyclisation. Synlett. 26(18). 2570–2574. 7 indexed citations

4.

Dirat, Olivier, et al.. (2006). Regioselective synthesis of 4-(2-alkyl-5-methyl-2H-pyrazol-3-yl)-piperidines. Tetrahedron Letters. 47(11). 1729–1731. 22 indexed citations

5.

Dirat, Olivier, Jason Elliott, Richard A. Jelley, A. Brian Jones, & Michael Reader. (2006). Expeditious synthesis of novel NK1 antagonists based on a 1,2,4-trisubstituted cyclohexane. Tetrahedron Letters. 47(8). 1295–1298. 7 indexed citations

6.

Chattopadhyay, Shital K., et al.. (2000). Towards a total synthesis of ulapualide A. Concise synthetic routes to the tris-oxazole ring system and tris-oxazole macrolide core in ulapualides, kabiramides, halichondramides, mycalolides and halishigamides. Journal of the Chemical Society Perkin Transactions 1. 2415–2428. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact